People · Operator
Named in public records as an officer, director or promoter · active 2016–2020 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zymergen Inc. | — | Other Technology | Growth/Late | $580.2M | $13.2B | 2016 |
| Insitro, Inc. | — | Biotechnology | Series D+ | $143.2M | $5.9B | 2020 |
Duane Valz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Duane Valz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Nelsen | 1 | 22 |
| Matt Ocko | 1 | 13 |
| Rohit Sharma | 1 | 10 |
| Vijay Pande | 1 | 9 |
| Paul Jansen | 1 | 3 |
| Daphne Koller | 1 | 3 |
| Steven Chu | 1 | 2 |
| Aaron Kimball | 1 | 2 |
| Zachariah Serber | 1 | 2 |
| Tom Stephenson | 1 | 2 |
| Judy Gilbert | 1 | 1 |
| Zach Serber | 1 | 1 |
| Jed Dean | 1 | 1 |
| Richard Pieters | 1 | 1 |
| Deep Nishar | 1 | 1 |
| Joshua Hoffman | 1 | 1 |
| Erik (Jed) Dean | 1 | 1 |
| Enakshi Singh | 1 | 1 |
| Sandra Miley | 1 | 1 |
| Mary Rozenman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.